文献速递针灸推拿中药与中成药合理使用

针灸联合阿片类药物治疗癌痛的实用性随机对照预试验

Acupuncture combined with opioids for cancer pain: a pilot pragmatic randomized controlled trial.
PubMed 文献 · Acupunct Med · 2021-11-10

结果显示针灸组疼痛评分至少下降2分的比例为93%(14/15),对照组为57%(8/14),风险差36.1%(95%CI 7.4%-65.0%),无严重不良事件。

要点

  • 针灸作为癌痛辅助治疗在真实医院环境中可行且患者可接受。
  • 联合针灸组疼痛NRS下降≥2分比例高于对照组,差异有统计学意义。
  • 研究为预试验,临床疗效需进一步大样本验证。

核心结论

  • 在常规镇痛基础上加用针灸治疗癌痛是可行且可接受的,临床效果需进一步评估。

研究设计与样本

  • 疗程1周,随访2周,共4次针灸,分别在第1/2/4/6天实施。

主要发现

  • 疼痛强度与每日阿片类药物用量总体趋势均偏向针灸组。
  • 治疗结束时NRS至少下降2分的比例:针灸组93%(n=14/15),对照组57%(n=8/14),风险差36.1%(95%CI 7.4%-65.0%),相对风险1.63(95%CI 1.02-2.62),p=0.04。
  • 无严重不良事件,治疗期间无脱落。

关键数值与推荐

  • 疼痛强度采用数值评定量表(NRS)测量,并记录每日阿片类药物剂量。
  • 主要可行性指标包括招募、干预实施与脱落情况;疗效指标为NRS下降≥2分的比例及阿片用量趋势。

临床怎么用

  • 肿瘤科中重度癌痛患者可在常规药物镇痛基础上考虑联合针灸作为辅助治疗。
  • 针灸方案为1周内4次,可结合NRS与阿片日剂量动态评估效果。

局限性

  • 随访时间短(2周),长期效果与安全性未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Given the existing evidence for the analgesic effect of acupuncture, the current study aimed to assess whether acupuncture could be feasible and manageable as an adjunctive therapy for cancer pain in a real-world hospital setting. METHODS: Thirty patients in an Oncology department with moderate or severe pain were recruited and randomized to an adjunctive acupuncture group or control group, who received pharmacotherapy for pain management without acupuncture. The duration of the treatment course was 1 week with a 2-week follow-up. In total, four acupuncture sessions were administered, on days 1/2/4/6 of the trial. Pain intensity was measured using a numerical rating scale (NRS) and the daily opioid dose was recorded. RESULTS: The overall trends favored acupuncture for both pain intensity and daily opioid consumption. The proportion of participants experiencing at least a 2-point reduction in the NRS at the end of the treatment was 93% (n = 14/15) for the acupuncture group and 57% (n = 8/14) for the control group (risk difference (RD) 36.1%, 95% confidence interval (CI) [7.4%-65.0%]; relative risk (RR) 1.63, 95% CI [1.02-2.62]; p = 0.04). There were no serious adverse events and no dropouts during the treatment. CONCLUSION: This pilot study showed that adding acupuncture to routine analgesia for patients with cancer pain was feasible and acceptable to patients. The clinical effects of adding acupuncture as an adjunctive therapy need to be further evaluated. CLINICAL TRIAL REGISTRATION NUMBER: ChiCTR1800017023 (Chinese Clinical Trial Registry).

来源:Acupunct Med,查看原文。版权归原作者所有。

引用

  1. He Y, Zhang H, Li Y, et al. Acupuncture combined with opioids for cancer pain: a pilot pragmatic randomized controlled trial. Acupunct Med. 2021. PMID: 34755569. doi:10.1177/09645284211056016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。